These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36649139)

  • 41. Recent advances in heme biocatalysis engineering.
    Schmitz LM; Rosenthal K; Lütz S
    Biotechnol Bioeng; 2019 Dec; 116(12):3469-3475. PubMed ID: 31483477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanding P450 catalytic reaction space through evolution and engineering.
    McIntosh JA; Farwell CC; Arnold FH
    Curr Opin Chem Biol; 2014 Apr; 19():126-34. PubMed ID: 24658056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catalytic C-H amination: a reaction now accessible to engineered natural enzymes.
    Mahy JP; Ciesielski J; Dauban P
    Angew Chem Int Ed Engl; 2014 Jul; 53(27):6862-4. PubMed ID: 24895319
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification of novel cytochrome P450 monooxygenases from actinomycetes capable of intermolecular oxidative C-C coupling reactions.
    Okazawa A; Yamanishi K; Katsuyama N; Kitazawa S; Ogawa T; Ohta D
    J Biosci Bioeng; 2020 Jan; 129(1):23-30. PubMed ID: 31506243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigating the Function of Cryptic Cytochalasan Cytochrome P450 Monooxygenases Using Combinatorial Biosynthesis.
    Wang C; Becker K; Pfütze S; Kuhnert E; Stadler M; Cox RJ; Skellam E
    Org Lett; 2019 Nov; 21(21):8756-8760. PubMed ID: 31644300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of alkylguaiacol-degrading cytochromes P450 for the biocatalytic valorization of lignin.
    Fetherolf MM; Levy-Booth DJ; Navas LE; Liu J; Grigg JC; Wilson A; Katahira R; Beckham GT; Mohn WW; Eltis LD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25771-25778. PubMed ID: 32989155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineering and application of enzymes for lipid modification, an update.
    Zorn K; Oroz-Guinea I; Brundiek H; Bornscheuer UT
    Prog Lipid Res; 2016 Jul; 63():153-64. PubMed ID: 27301784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploiting a C-N Bond Forming Cytochrome P450 Monooxygenase for C-S Bond Formation.
    Morita I; Mori T; Mitsuhashi T; Hoshino S; Taniguchi Y; Kikuchi T; Nagae K; Nasu N; Fujita M; Ohwada T; Abe I
    Angew Chem Int Ed Engl; 2020 Mar; 59(10):3988-3993. PubMed ID: 31886618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research advances in cytochrome P450-catalysed pharmaceutical terpenoid biosynthesis in plants.
    Zheng X; Li P; Lu X
    J Exp Bot; 2019 Sep; 70(18):4619-4630. PubMed ID: 31037306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes.
    Strohmaier SJ; De Voss JJ; Jurva U; Andersson S; Gillam EMJ
    Drug Metab Dispos; 2020 Jun; 48(6):432-437. PubMed ID: 32238418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxygenating Biocatalysts for Hydroxyl Functionalisation in Drug Discovery and Development.
    Charlton SN; Hayes MA
    ChemMedChem; 2022 Jun; 17(12):e202200115. PubMed ID: 35385205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytochrome P450: taming a wild type enzyme.
    Jung ST; Lauchli R; Arnold FH
    Curr Opin Biotechnol; 2011 Dec; 22(6):809-17. PubMed ID: 21411308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an improved Amplex Red peroxidation activity assay for screening cytochrome P450 variants and identification of a novel mutant of the thermophilic CYP119.
    Başlar MS; Sakallı T; Güralp G; Kestevur Doğru E; Haklı E; Surmeli NB
    J Biol Inorg Chem; 2020 Oct; 25(7):949-962. PubMed ID: 32924072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engineering the third wave of biocatalysis.
    Bornscheuer UT; Huisman GW; Kazlauskas RJ; Lutz S; Moore JC; Robins K
    Nature; 2012 May; 485(7397):185-94. PubMed ID: 22575958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cytochrome P450 engineering database: Integration of biochemical properties.
    Sirim D; Wagner F; Lisitsa A; Pleiss J
    BMC Biochem; 2009 Nov; 10():27. PubMed ID: 19909539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The molecular basis and enzyme engineering strategies for improvement of coupling efficiency in cytochrome P450s.
    Meng S; Ji Y; Zhu L; Dhoke GV; Davari MD; Schwaneberg U
    Biotechnol Adv; 2022 Dec; 61():108051. PubMed ID: 36270499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved cyclopropanation activity of histidine-ligated cytochrome P450 enables the enantioselective formal synthesis of levomilnacipran.
    Wang ZJ; Renata H; Peck NE; Farwell CC; Coelho PS; Arnold FH
    Angew Chem Int Ed Engl; 2014 Jun; 53(26):6810-3. PubMed ID: 24802161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates.
    Sun H; Zhang H; Ang EL; Zhao H
    Bioorg Med Chem; 2018 Apr; 26(7):1275-1284. PubMed ID: 28709846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dispelling the myths--biocatalysis in industrial synthesis.
    Schoemaker HE; Mink D; Wubbolts MG
    Science; 2003 Mar; 299(5613):1694-7. PubMed ID: 12637735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereodivergent atom-transfer radical cyclization by engineered cytochromes P450.
    Zhou Q; Chin M; Fu Y; Liu P; Yang Y
    Science; 2021 Dec; 374(6575):1612-1616. PubMed ID: 34941416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.